$HIPH if their quarterly revenue run-rate reaches our $2M in annual sales target this year it could reach the $0.0125 level, which is a valuation similar to other CBD-infused product-centric companies, and some apparel firms. This target may double in a year’s time as sales in 2021 could reach $5-7M with 20% EBITDA margins.
https://www.goldmanresearch.com/202002201271/...hesis.html